REVITALIST LIFESTYLE AND WELLNESS LTD. (“Revitalist” or the “Company”) (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is pleased to announce that it has executed an asset purchase agreement (“Agreement”) dated January 11, 2022, to acquire a Ketamine clinic located in Jacksonville, Florida (“Acquisition”). Revitalist had previously announced the Acquisition non-binding letter of intent on October 27, 2021. This Acquisition represents the ninth clinic for the Company and is expected to commence under the Revitalist brand by February 1, 2022. The Jacksonville clinic was formed in 2017 and continues to be managed by Dr. Nicholas Kalynych who has over 30 years of experience in health care.

Dr. Nicholas Kalynych commented: “I am very pleased to be teaming up with Revitalist to accelerate growth of the practice in Jacksonville. With this acquisition complete, we are now positioned to significantly expand our service offerings and patient count, which will provide the Jacksonville community greater access to care.”

Kathryn Walker, CEO of Revitalist, commented: “With the closing of this acquisition, Revitalist will have nine clinics operating in six states. We are well on our way to executing our growth plans. On behalf of the entire company, I would like to formally welcome Dr. Kalynych and his team to Revitalist. We look forward to implementing our business model in Jacksonville and utilizing the decades of experience provided by Dr. Kalynych to offer exceptional treatments to the community.”

Pursuant to the terms of the Agreement, the consideration for the Acquisition is $100,000 USD. The consideration payable is $60,000 USD in cash and $40,000 in common shares. The share consideration will be issued at the greater of $0.50/share and the 20-day volume weighted average share price preceding the issue date and will be issued 50% in 12 months and 50% in 24 months following the closing of the Acquisition.

ABOUT REVITALIST LIFESTYLE AND WELLNESS LTD.

Revitalist Lifestyle and Wellness Ltd. (CSE: CALM) (OTC: RVLWF) (FSE: 4DO) is a publicly traded company, headquartered in Knoxville, Tennessee, with seven clinics operating across the United States and expanding. Revitalist is dedicated to empowering individuals toward an improved quality of well-being through a combination of comprehensive care and future-centric treatments provided by medical professionals, mental health experts, and chronic pain specialists. Since opening their first clinic in 2018, Revitalist has provided thousands of infusions for patients suffering from treatment-resistant conditions. Additionally, Revitalist offers a number of lifestyle optimization services and vitamin infusions that can bring anyone closer to total wellness. For additional information and to be added to the Company’s mailing list, please click here.

Twitter: @RevitalistCorp

Facebook: @RevitalistLifestyleandWellnessLtd.

Instagram: @RevitalistCorp

LinkedIn: @RevitalistLifestyleAndWellnessLtd

On Behalf of the Board:

Kathryn Walker

Chief Executive Officer

Forward Looking Statements

This news release contains forward-looking statements and information within the meaning of applicable securities legislation. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.

Risks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220112005347/en/